Cell Line : NCI-H508
Cellosaurus Index : CVCL_1564
Cellosaurus ID : NCI-H508
CTRP1 Name
, CTRP2 Name
: NCIH508
GDSC1 Name
, GDSC2 Name
: NCI-H508
CCLE Name
: NCIH508_LARGE_INTESTINE
Cancer Type : large_intestine
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| NCI-H508 | (-)-gallocatechin-3-monogallate | CTRP1 | 2.3125 | 296.0000 |
|
| NCI-H508 | (5Z)-7-Oxozeaenol | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | 10-DEBC | CTRP1 | 0.6250 | 80.0000 |
|
| NCI-H508 | 16-beta-bromoandrosterone | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| NCI-H508 | 16,16-dimethylprostaglandin-E2 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | 1S,3R-RSL-3 | CTRP2,CTRP1 | 0.0010 | 33.0000 |
|
| NCI-H508 | 2-bromopyruvate | CTRP1 | 4.1667 | 533.3300 |
|
| NCI-H508 | 2-fluoropalmitic acid | CTRP1 | 1.1562 | 148.0000 |
|
| NCI-H508 | 2,4-dideoxy-DC-45-A2 | CTRP1 | 0.0163 | 2.0833 |
|
| NCI-H508 | 3-aminobenzamide | CTRP1 | 0.9564 | 122.4100 |
|
| NCI-H508 | 3-chloro-L-alanine | CTRP1 | 0.0163 | 2.0833 |
|
| NCI-H508 | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | 4-IPP | CTRP1 | 1.0417 | 133.3300 |
|
| NCI-H508 | 4-methylfasudil | CTRP1 | 1.0417 | 133.3300 |
|
| NCI-H508 | 5-Fluorouracil | GDSC2 | 0.0195 | 20.0000 |
|
| NCI-H508 | 6-diazo-5-oxo-L-norleucine | CTRP1 | 1.0417 | 133.3300 |
|
| NCI-H508 | 7-nitroindazole | CTRP1 | 2.0833 | 266.6700 |
|
| NCI-H508 | 965-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | 993-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | A-804598 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | AA-COCF3 | CTRP2,CTRP1 | 0.0081 | 266.6700 |
|
| NCI-H508 | abiraterone | CTRP2 | 0.0005 | 17.0000 |
|
| NCI-H508 | ABT-751 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | ABT737 | GDSC2,CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| NCI-H508 | AC55649 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | Afatinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | AG14361 | CTRP1 | 0.6510 | 83.3330 |
|
| NCI-H508 | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | AGI-6780 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | AGK-2 | GDSC2,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | AICA Ribonucleotide | GDSC1 | 7.8125 | 2000.0000 |
|
| NCI-H508 | Alda-1 | CTRP1 | 1.0417 | 133.3300 |
|
| NCI-H508 | Alisertib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H508 | Alpelisib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | AM-580 | CTRP2,CTRP1 | 0.0160 | 533.3300 |
|
| NCI-H508 | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | ASN 05257430 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| NCI-H508 | AT-406 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | AT13148 | GDSC2 | 0.0080 | 8.0000 |
|
| NCI-H508 | AT7867 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | austocystin D | CTRP1 | 0.2891 | 37.0000 |
|
| NCI-H508 | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | avrainvillamide | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | Axitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | AZ20 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | AZD-7545 | CTRP2,CTRP1 | 0.0023 | 74.0000 |
|
| NCI-H508 | AZD1208 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | AZD1332 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | AZD1480 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H508 | AZD2014 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | AZD3514 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H508 | AZD4547 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | AZD4877 | GDSC1 | 0.0002 | 0.0390 |
|
| NCI-H508 | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | AZD5438 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | AZD5582 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | AZD6094 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H508 | AZD6482 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | AZD6738 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | AZD7762 | GDSC1,GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| NCI-H508 | AZD7969 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | AZD8055 | GDSC1,GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| NCI-H508 | AZD8186 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| NCI-H508 | AZD8835 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | AZD8931 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | B02 | CTRP2,CTRP1 | 0.0041 | 133.3300 |
|
| NCI-H508 | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | batimastat | CTRP1 | 1.1562 | 148.0000 |
|
| NCI-H508 | Bax channel blocker | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | BAY ACCi | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | BAY AKT1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | BAY-HDAC11_1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | BAY-HDAC11_2 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | BAY-HDAC11_4 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | BAY-MPS-combo 2 (paclitaxel 1 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| NCI-H508 | BAY-MPS-combo-1 (paclitaxel 5 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| NCI-H508 | BAY-MPS1 | GDSC1 | 0.0117 | 3.0000 |
|
| NCI-H508 | BEC | CTRP1 | 2.0833 | 266.6700 |
|
| NCI-H508 | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Bexarotene | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BI-2536 | GDSC2,CTRP2,CTRP1 | 0.0005 | 33.3330 |
|
| NCI-H508 | BIBR-1532 | GDSC2,CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| NCI-H508 | Bicalutamide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BIX-01294 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | blebbistatin | CTRP1 | 1.0417 | 133.3300 |
|
| NCI-H508 | Bleomycin (10 uM) | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | Bleomycin (50 uM) | GDSC1 | 0.1953 | 50.0000 |
|
| NCI-H508 | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BML-259 | CTRP1 | 2.0833 | 266.6700 |
|
| NCI-H508 | BMS-191011 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BMS-299897 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | BMS-345541 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BMS-536924 | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| NCI-H508 | BMS-641988 | CTRP1 | 0.2891 | 37.0000 |
|
| NCI-H508 | BMS-754807 | GDSC2,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | Bortezomib | GDSC2,CTRP2,CTRP1 | 0.0000 | 0.1300 |
|
| NCI-H508 | Bosutinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BPTES | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| NCI-H508 | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H508 | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | BRD-A94377914 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | BRD-K03536150 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K03911514 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K04800985 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K09344309 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K20514654 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| NCI-H508 | BRD-K27188169 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K27188169:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H508 | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K33199242 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K34222889 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K35604418 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K50799972 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K55116708 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K55473186 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| NCI-H508 | BRD-K79669418 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| NCI-H508 | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD-K99584050 | CTRP2 | 0.0020 | 33.0000 |
|
| NCI-H508 | BRD-M00053801 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD0476 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | BRD0713 | CTRP1 | 0.6250 | 80.0000 |
|
| NCI-H508 | BRD1429 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | BRD1566 | CTRP1 | 0.2683 | 34.3400 |
|
| NCI-H508 | BRD1812 | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| NCI-H508 | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H508 | BRD2296 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | BRD2572 | CTRP1 | 0.6250 | 80.0000 |
|
| NCI-H508 | BRD2762 | CTRP1 | 0.6250 | 80.0000 |
|
| NCI-H508 | BRD32048 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | BRD4046 | CTRP1 | 0.6250 | 80.0000 |
|
| NCI-H508 | BRD4132 | CTRP2,CTRP1 | 0.0049 | 160.0000 |
|
| NCI-H508 | BRD4354 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | BRD4372 | CTRP1 | 0.6250 | 80.0000 |
|
| NCI-H508 | BRD4470 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | BRD4479 | CTRP1 | 0.1823 | 23.3330 |
|
| NCI-H508 | BRD4770 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | BRD55319 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| NCI-H508 | BRD5586 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | BRD5802 | CTRP1 | 0.6250 | 80.0000 |
|
| NCI-H508 | BRD6150 | CTRP1 | 0.6250 | 80.0000 |
|
| NCI-H508 | BRD6340 | CTRP2,CTRP1 | 0.0010 | 40.0000 |
|
| NCI-H508 | BRD63610 | CTRP1 | 0.0081 | 1.0417 |
|
| NCI-H508 | BRD6368 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | BRD6413 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | BRD6430 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | BRD6825 | CTRP1 | 0.6250 | 80.0000 |
|
| NCI-H508 | BRD7137 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | BRD8097 | CTRP1 | 0.6250 | 80.0000 |
|
| NCI-H508 | BRD8418 | CTRP1 | 0.6250 | 80.0000 |
|
| NCI-H508 | BRD8899 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | BRD8958 | CTRP2,CTRP1 | 0.0020 | 66.6670 |
|
| NCI-H508 | BRD9571 | CTRP1 | 0.6250 | 80.0000 |
|
| NCI-H508 | BRD9647 | CTRP2,CTRP1 | 0.0010 | 66.6670 |
|
| NCI-H508 | BRD9658 | CTRP1 | 0.6250 | 80.0000 |
|
| NCI-H508 | BRD9876 | CTRP2,CTRP1 | 0.0041 | 133.3300 |
|
| NCI-H508 | brefeldin A | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| NCI-H508 | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | BX795 | GDSC1,GDSC2,CTRP1 | 0.0100 | 33.3330 |
|
| NCI-H508 | C6-ceramide | CTRP2 | 0.0020 | 33.0000 |
|
| NCI-H508 | Cabozantinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H508 | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Capivasertib | GDSC1 | 0.1172 | 30.0000 |
|
| NCI-H508 | capsaicin | CTRP1 | 4.1667 | 533.3300 |
|
| NCI-H508 | carbamazepine | CTRP1 | 2.5000 | 320.0000 |
|
| NCI-H508 | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 47.0000 |
|
| NCI-H508 | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 25.0000 |
|
| NCI-H508 | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | CAY10594 | CTRP2,CTRP1 | 0.0020 | 66.6670 |
|
| NCI-H508 | CAY10618 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | CCT-018159 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | CCT007093 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | CCT036477 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | CCT245232 | GDSC1 | 0.0008 | 0.2000 |
|
| NCI-H508 | CCT245467 | GDSC1 | 0.0008 | 0.2000 |
|
| NCI-H508 | CD-1530 | CTRP2,CTRP1 | 0.0041 | 133.3300 |
|
| NCI-H508 | CD-437 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| NCI-H508 | Cediranib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | cerulenin | CTRP2,CTRP1 | 0.0045 | 150.0000 |
|
| NCI-H508 | Cetuximab | GDSC1 | 0.2570 | 65.8000 |
|
| NCI-H508 | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | chaetocin | CTRP1 | 0.0020 | 0.2600 |
|
| NCI-H508 | CHEMBL1222381 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| NCI-H508 | CHEMBL374350 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | CHEMBL399379 | CTRP1 | 2.0833 | 266.6700 |
|
| NCI-H508 | CHIR-99021 | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0024 | 80.0000 |
|
| NCI-H508 | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H508 | CHM-1 | CTRP2,CTRP1 | 0.0005 | 16.0000 |
|
| NCI-H508 | CI-1040 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | CI-976 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| NCI-H508 | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | ciclosporin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | CID 2853753 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | CIL41 | CTRP2,CTRP1 | 0.0049 | 160.0000 |
|
| NCI-H508 | CIL55 | CTRP1 | 0.0781 | 10.0000 |
|
| NCI-H508 | CIL55A | CTRP2,CTRP1 | 0.0024 | 80.0000 |
|
| NCI-H508 | CIL56 | CTRP2,CTRP1 | 0.0001 | 2.5000 |
|
| NCI-H508 | CIL70 | CTRP2,CTRP1 | 0.0012 | 40.0000 |
|
| NCI-H508 | Cisplatin | GDSC1 | 0.0117 | 10.0000 |
|
| NCI-H508 | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | COL-3 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Compound 10b | CTRP1 | 1.1562 | 148.0000 |
|
| NCI-H508 | Compound 110 | CTRP1 | 0.5781 | 74.0000 |
|
| NCI-H508 | Compound 11e | CTRP1 | 0.0130 | 1.6667 |
|
| NCI-H508 | Compound 12 | CTRP1 | 0.2891 | 37.0000 |
|
| NCI-H508 | Compound 1541A | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| NCI-H508 | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Compound 23 citrate | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | Compound 4 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | Compound 44 | CTRP1 | 1.0417 | 133.3300 |
|
| NCI-H508 | Compound 7d-cis | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | CR-1-31B | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | Crizotinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H508 | CRT0105446 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | CRT0105950 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | CRT0160829 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H508 | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | curcumin | CTRP1 | 1.2500 | 160.0000 |
|
| NCI-H508 | cyanoquinoline 11 | CTRP2,CTRP1 | 0.0041 | 133.3300 |
|
| NCI-H508 | Cyclophosphamide | GDSC2,CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H508 | CYT-997 | CTRP1 | 0.0260 | 3.3333 |
|
| NCI-H508 | Cytarabine | GDSC1 | 0.0078 | 2.0000 |
|
| NCI-H508 | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | cytochalasin B | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | cytosporone B | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | Dabrafenib | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| NCI-H508 | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Dactinomycin | GDSC2 | 0.0008 | 0.8000 |
|
| NCI-H508 | Dactolisib | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0003 | 17.0000 |
|
| NCI-H508 | dalcetrapib | CTRP1 | 2.0687 | 264.8000 |
|
| NCI-H508 | Daporinad | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0000 | 2.0000 |
|
| NCI-H508 | darinaparsin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | Dasatinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | DC-45-A2 | CTRP1 | 0.2891 | 37.0000 |
|
| NCI-H508 | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H508 | dexamethasone | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | DG-041 | CTRP1 | 1.0417 | 133.3300 |
|
| NCI-H508 | Dinaciclib | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H508 | DL-TBOA | CTRP1 | 4.1667 | 533.3300 |
|
| NCI-H508 | Docetaxel | GDSC1,GDSC2 | 0.0000 | 0.0125 |
|
| NCI-H508 | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H508 | Doramapimod | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Doxorubicin | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H508 | Dyrk1b_0191 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | EHT-1864 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | ELCPK | CTRP2,CTRP1 | 0.0000 | 0.4000 |
|
| NCI-H508 | Elesclomol | GDSC1,GDSC2 | 0.0002 | 0.2000 |
|
| NCI-H508 | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | endo-IWR-1 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | Entinostat | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | EphB4_9721 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | epigallocatechin-3-monogallate | CTRP2 | 0.0090 | 300.0000 |
|
| NCI-H508 | Epirubicin | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | erastin | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| NCI-H508 | erastin-A8 | CTRP1 | 0.1250 | 16.0000 |
|
| NCI-H508 | Erlotinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | etomoxir | CTRP2,CTRP1 | 0.0090 | 300.0000 |
|
| NCI-H508 | Etoposide | CTRP2,CTRP1 | 0.0009 | 28.3180 |
|
| NCI-H508 | ETP-46464 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | fatostatin | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | Fedratinib | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| NCI-H508 | FEN1_3940 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | FGFR_0939 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H508 | FGFR_3831 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | FGIN-1-27 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | fluoropyruvate | CTRP1 | 1.1562 | 148.0000 |
|
| NCI-H508 | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H508 | Flutamide | CTRP1 | 0.7542 | 96.5330 |
|
| NCI-H508 | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Foretinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | FQI-1 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | FQI-2 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | FS106 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | FS112 | GDSC1 | 0.0195 | 5.0000 |
|
| NCI-H508 | Fulvestrant | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| NCI-H508 | fumagillol | CTRP1 | 4.1667 | 533.3300 |
|
| NCI-H508 | fumonisin B1 | CTRP2,CTRP1 | 0.0150 | 504.0000 |
|
| NCI-H508 | FY012 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | FY026 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | FY069 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | GANT-58 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | Gefitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Gemcitabine | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0002 | 33.0000 |
|
| NCI-H508 | glibenclamide | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | Gly-Gly-PALO | CTRP1 | 2.0833 | 266.6700 |
|
| NCI-H508 | GMX-1778 | CTRP2,CTRP1 | 0.0000 | 0.2900 |
|
| NCI-H508 | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | gossypol | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| NCI-H508 | GSK-2334470 | CTRP1 | 0.0026 | 0.3333 |
|
| NCI-H508 | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | GSK-J4 | GDSC1 | 0.1172 | 30.0000 |
|
| NCI-H508 | GSK1059615 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | GSK1904529A | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H508 | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | GSK2636771 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | GSK269962A | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | GSK343 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H508 | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | GW-405833 | CTRP2,CTRP1 | 0.0041 | 133.3300 |
|
| NCI-H508 | GW441756 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H508 | GW843682X | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | HBX-41108 | CTRP2 | 0.0041 | 66.0000 |
|
| NCI-H508 | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | HG-5-113-01 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | HG-5-88-01 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | HLI 373 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | hyperforin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | I-BET-762 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | I-BET151 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | I-CBP112 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | IAP_5620 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | IAP_7638 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | Ibrutinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | IC-87114 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | ICL1100013 | GDSC1 | 0.0781 | 20.0000 |
|
| NCI-H508 | idarubicin | CTRP1 | 0.0020 | 0.2600 |
|
| NCI-H508 | Idelalisib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | IGFR_3801 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | importazole | CTRP2,CTRP1 | 0.0061 | 200.0000 |
|
| NCI-H508 | indisulam | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | IOX2 | GDSC1,GDSC2 | 0.0004 | 0.5000 |
|
| NCI-H508 | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Irinotecan | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H508 | isoevodiamine | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | isoliquiritigenin | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | isonicotinohydroxamic acid | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | ISOX | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| NCI-H508 | itraconazole | CTRP2,CTRP1 | 0.0005 | 33.3330 |
|
| NCI-H508 | IU1 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H508 | JAK1_3715 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | JAK3_7406 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | JNK Inhibitor VIII | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H508 | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H508 | JQ1 | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| NCI-H508 | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | JW-55 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | JW-74 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | JZL-184 | CTRP1 | 0.2891 | 37.0000 |
|
| NCI-H508 | kahalalide F | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | KH-CB19 | CTRP2 | 0.0005 | 17.0000 |
|
| NCI-H508 | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | kinetin riboside | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | Ko-143 | CTRP2,CTRP1 | 0.0041 | 133.3300 |
|
| NCI-H508 | KPT185 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H508 | KU 0060648 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | KU-55933 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | KU-60019 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | L-685458 | CTRP2 | 0.0011 | 37.0000 |
|
| NCI-H508 | Lapatinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | LCL161 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | LDN-193189 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | LE-135 | CTRP2,CTRP1 | 0.0020 | 66.6670 |
|
| NCI-H508 | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| NCI-H508 | Lenalidomide | GDSC1,GDSC2,CTRP1 | 0.0100 | 592.0000 |
|
| NCI-H508 | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Lestaurtinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H508 | leucascandrolide A | CTRP1 | 0.0163 | 2.0833 |
|
| NCI-H508 | LFM-A13 | CTRP1 | 2.8935 | 370.3700 |
|
| NCI-H508 | LGK974 | GDSC2 | 0.0098 | 10.0000 |
|
| NCI-H508 | Linifanib | CTRP2 | 0.0020 | 33.0000 |
|
| NCI-H508 | Linsitinib | GDSC2,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | lonidamine | CTRP1 | 4.6250 | 592.0000 |
|
| NCI-H508 | losartan | CTRP1 | 4.1667 | 533.3300 |
|
| NCI-H508 | lovastatin acid | CTRP2,CTRP1 | 0.0041 | 133.3300 |
|
| NCI-H508 | LRRK2-IN-1 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Luminespib | GDSC2 | 0.0003 | 0.2500 |
|
| NCI-H508 | LY-2183240 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | LY2109761 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H508 | m-3M3-FBS | CTRP1 | 2.0833 | 266.6700 |
|
| NCI-H508 | manumycin A | CTRP2,CTRP1 | 0.0009 | 30.2680 |
|
| NCI-H508 | maraviroc | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | marinopyrrole A | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Masitinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | MCT1_6447 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | MCT4_1422 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | MDV-3100 | CTRP1 | 0.0065 | 0.8333 |
|
| NCI-H508 | Merck60 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | Methotrexate | GDSC1,GDSC2,CTRP2 | 0.0008 | 66.0000 |
|
| NCI-H508 | methylstat | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | MG-132 | GDSC2 | 0.0040 | 4.0000 |
|
| NCI-H508 | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | MI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | minoxidil | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | MIRA-1 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Mirin | GDSC1,GDSC2 | 0.1001 | 100.0000 |
|
| NCI-H508 | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H508 | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | MK-1775 | GDSC2,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | MK-2206 | GDSC1,GDSC2,CTRP1 | 0.0098 | 33.3330 |
|
| NCI-H508 | MK-591 | CTRP1 | 2.0833 | 266.6700 |
|
| NCI-H508 | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H508 | ML006 | CTRP2,CTRP1 | 0.0160 | 533.3300 |
|
| NCI-H508 | ML007 | CTRP1 | 0.2891 | 37.0000 |
|
| NCI-H508 | ML013 | CTRP1 | 0.5208 | 66.6670 |
|
| NCI-H508 | ML030 | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| NCI-H508 | ML050 | CTRP2,CTRP1 | 0.0020 | 66.6670 |
|
| NCI-H508 | ML100 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | ML101 | CTRP1 | 2.0833 | 266.6700 |
|
| NCI-H508 | ML150 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | ML159 | CTRP1 | 1.0417 | 133.3300 |
|
| NCI-H508 | ML160 | CTRP1 | 1.0417 | 133.3300 |
|
| NCI-H508 | ML162 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | ML203 | CTRP2,CTRP1 | 0.0011 | 296.0000 |
|
| NCI-H508 | ML210 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | ML214 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| NCI-H508 | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| NCI-H508 | ML334 diastereomer | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H508 | MLN2238 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Motesanib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H508 | MPEP | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | myriocin | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | N-oxalyl-D-phenylalanine | CTRP1 | 4.1667 | 533.3300 |
|
| NCI-H508 | N22899-6-C1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | N23918-95-7 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | N24798-49-A1 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | N9-isopropylolomoucine | CTRP2,CTRP1 | 0.0120 | 408.5000 |
|
| NCI-H508 | nakiterpiosin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | narciclasine | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | Navitoclax | GDSC1,GDSC2,CTRP1 | 0.0020 | 33.3330 |
|
| NCI-H508 | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| NCI-H508 | necrostatin-1 | CTRP2,CTRP1 | 0.0160 | 533.3300 |
|
| NCI-H508 | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | neopeltolide | CTRP1 | 0.0000 | 1.1533 |
|
| NCI-H508 | neratinib | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | nifedipine | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | Nilotinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | nimodipine | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | NPC-26 | CTRP2,CTRP1 | 0.0012 | 40.0000 |
|
| NCI-H508 | NSC 74859 | CTRP2,CTRP1 | 0.0160 | 533.3300 |
|
| NCI-H508 | NSC23766 | CTRP2,CTRP1 | 0.0160 | 533.3300 |
|
| NCI-H508 | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | NSC632839 | CTRP2,CTRP1 | 0.0020 | 33.3330 |
|
| NCI-H508 | NSC95397 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | NU 1025 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | NU7441 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H508 | Nutlin-3a | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0045 | 150.0000 |
|
| NCI-H508 | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | NVP-ADW742 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | NVP-AUY922 | CTRP1 | 0.0001 | 33.3330 |
|
| NCI-H508 | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | NVP-TAE684 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Obatoclax Mesylate | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | Olaparib | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0045 | 150.0000 |
|
| NCI-H508 | oligomycin A | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | omacetaxine mepesuccinate | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | orteronel | CTRP1 | 1.0417 | 133.3300 |
|
| NCI-H508 | OSI-027 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | OSI-930 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H508 | OSW-1 | CTRP1 | 0.0010 | 16.6670 |
|
| NCI-H508 | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| NCI-H508 | Oxaliplatin | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | P-0850 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | PAC-1 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | Paclitaxel | GDSC2,CTRP2 | 0.0001 | 66.0000 |
|
| NCI-H508 | Palbociclib | GDSC1,GDSC2 | 0.0039 | 4.0000 |
|
| NCI-H508 | palmostatin B | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | panduratin A | CTRP1 | 2.0833 | 266.6700 |
|
| NCI-H508 | parbendazole | CTRP2,CTRP1 | 0.0020 | 66.6670 |
|
| NCI-H508 | PARP_0108 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H508 | PARP_9482 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H508 | PARP_9495 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H508 | Parthenolide | CTRP2,CTRP1 | 0.0020 | 66.6670 |
|
| NCI-H508 | Pazopanib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | PD 153035 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | PD0325901 | GDSC1,GDSC2 | 0.0010 | 2.5000 |
|
| NCI-H508 | PD173074 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H508 | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | PDMP | CTRP2,CTRP1 | 0.0065 | 213.3300 |
|
| NCI-H508 | Pemetrexed | CTRP1 | 2.3125 | 296.0000 |
|
| NCI-H508 | penfluridol | CTRP1 | 0.7813 | 100.0000 |
|
| NCI-H508 | Pevonedistat | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| NCI-H508 | PF-04217903 | CTRP1 | 1.0417 | 133.3300 |
|
| NCI-H508 | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | PF-3845 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | PF-4708671 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | PF-750 | CTRP1 | 2.0833 | 266.6700 |
|
| NCI-H508 | PFI-1 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | PFI3 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | PHA-793887 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | phloretin | CTRP2,CTRP1 | 0.0180 | 592.0000 |
|
| NCI-H508 | PI-103 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| NCI-H508 | PI3Ka_4409 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | Pictilisib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | pifithrin-alpha | CTRP2,CTRP1 | 0.0071 | 232.7700 |
|
| NCI-H508 | pifithrin-mu | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | PIK-75 | CTRP1 | 0.0023 | 0.2890 |
|
| NCI-H508 | PIK-93 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Piperlongumine | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0010 | 35.6930 |
|
| NCI-H508 | pitstop2 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | PJ 34 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | PK-11195 | CTRP1 | 4.1667 | 533.3300 |
|
| NCI-H508 | PL-DI | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| NCI-H508 | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | PLK_6522 | GDSC1 | 0.0024 | 0.6250 |
|
| NCI-H508 | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | PLX-4032 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | PLX-4720 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | PNU-74654 | CTRP1 | 2.0833 | 266.6700 |
|
| NCI-H508 | PP-30 | CTRP1 | 0.2891 | 37.0000 |
|
| NCI-H508 | PRIMA-1 | CTRP2,CTRP1 | 0.0051 | 170.0000 |
|
| NCI-H508 | PRIMA-1MET | GDSC2,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | PRL-3 Inhibitor I | CTRP2,CTRP1 | 0.0041 | 133.3300 |
|
| NCI-H508 | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | PT-630 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | purmorphamine | CTRP2,CTRP1 | 0.0046 | 150.0000 |
|
| NCI-H508 | PX-12 | CTRP2,CTRP1 | 0.0030 | 100.0000 |
|
| NCI-H508 | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | pyrvinium pamoate | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | QL-VIII-58 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | QL-XII-61 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | QS11 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | quinoclamine | CTRP1 | 0.2891 | 37.0000 |
|
| NCI-H508 | Quizartinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | R428 | CTRP2 | 0.0020 | 17.0000 |
|
| NCI-H508 | RAF_9304 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | Rapamycin | GDSC2,CTRP2,CTRP1 | 0.0001 | 37.0000 |
|
| NCI-H508 | Refametinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Repligen 136 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | RG-108 | CTRP2,CTRP1 | 0.0081 | 266.6700 |
|
| NCI-H508 | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| NCI-H508 | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | RITA | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | Ro-28-1675 | CTRP1 | 4.1667 | 533.3300 |
|
| NCI-H508 | RO-3306 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | rosiglitazone | CTRP1 | 2.0833 | 266.6700 |
|
| NCI-H508 | rotenone | CTRP1 | 0.0163 | 2.0833 |
|
| NCI-H508 | RS-23597-190 | CTRP1 | 4.1667 | 533.3300 |
|
| NCI-H508 | rTRAIL | GDSC1 | 0.0004 | 0.1000 |
|
| NCI-H508 | Rucaparib | GDSC1,GDSC2,CTRP1 | 0.0050 | 33.3330 |
|
| NCI-H508 | Ruxolitinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | salermide | CTRP2,CTRP1 | 0.0120 | 400.0000 |
|
| NCI-H508 | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 |
|
| NCI-H508 | Sapitinib | GDSC2 | 0.0049 | 5.0000 |
|
| NCI-H508 | Saracatinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H508 | SB-225002 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| NCI-H508 | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | SB216763 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| NCI-H508 | SB505124 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| NCI-H508 | SB590885 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H508 | SCH-529074 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | SCH-79797 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| NCI-H508 | SCH772984 | GDSC2 | 0.0049 | 5.0000 |
|
| NCI-H508 | Selisistat | CTRP2,CTRP1 | 0.0024 | 80.0000 |
|
| NCI-H508 | Selumetinib | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| NCI-H508 | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H508 | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H508 | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H508 | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H508 | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| NCI-H508 | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| NCI-H508 | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| NCI-H508 | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| NCI-H508 | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| NCI-H508 | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| NCI-H508 | selumetinib:vorinostat (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| NCI-H508 | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Sepantronium bromide | GDSC2,CTRP2,CTRP1 | 0.0000 | 10.0000 |
|
| NCI-H508 | Serdemetan | GDSC1,GDSC2,CTRP1 | 0.0100 | 33.3330 |
|
| NCI-H508 | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | SGC0946 | GDSC1,GDSC2 | 0.0005 | 0.5000 |
|
| NCI-H508 | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | SID 26681509 | CTRP2,CTRP1 | 0.0090 | 300.0000 |
|
| NCI-H508 | sildenafil | CTRP2,CTRP1 | 0.0160 | 533.3300 |
|
| NCI-H508 | simvastatin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| NCI-H508 | SJ-172550 | CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| NCI-H508 | SKI-II | CTRP2,CTRP1 | 0.0041 | 133.3300 |
|
| NCI-H508 | SL0101 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | SN-38 | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0000 | 10.0000 |
|
| NCI-H508 | SNS-032 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | SNX-2112 | CTRP2,CTRP1 | 0.0010 | 33.0000 |
|
| NCI-H508 | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| NCI-H508 | Sorafenib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | sotrastaurin | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | sparfosic acid | CTRP1 | 2.0833 | 266.6700 |
|
| NCI-H508 | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | SR-II-138A | CTRP2,CTRP1 | 0.0010 | 33.0000 |
|
| NCI-H508 | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Staurosporine | GDSC2 | 0.0078 | 2.0000 |
|
| NCI-H508 | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | SU11274 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | T-5345967 | CTRP2,CTRP1 | 0.0160 | 533.3300 |
|
| NCI-H508 | tacedinaline | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | tacrolimus | CTRP2,CTRP1 | 0.0023 | 74.0000 |
|
| NCI-H508 | Talazoparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | tamatinib | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | Tamoxifen | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0030 | 100.0000 |
|
| NCI-H508 | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Tanespimycin | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0010 | 33.0000 |
|
| NCI-H508 | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| NCI-H508 | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | TANK_1366 | GDSC1 | 0.0098 | 2.5000 |
|
| NCI-H508 | Taselisib | GDSC2 | 0.0098 | 10.0000 |
|
| NCI-H508 | Telomerase Inhibitor IX | GDSC2,CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| NCI-H508 | Temozolomide | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Temsirolimus | GDSC1,GDSC2,CTRP2 | 0.0008 | 66.0000 |
|
| NCI-H508 | Teniposide | CTRP2,CTRP1 | 0.0010 | 33.0000 |
|
| NCI-H508 | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | TGX-115 | CTRP1 | 4.1667 | 533.3300 |
|
| NCI-H508 | TGX221 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | tigecycline | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | tipifarnib-P1 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | tipifarnib-P2 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | Tivozanib | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | Topotecan | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | tosedostat | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| NCI-H508 | Tozasertib | GDSC2,CTRP1 | 0.0050 | 33.3330 |
|
| NCI-H508 | TPCA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Trametinib | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| NCI-H508 | Tretinoin | GDSC1,GDSC2,CTRP1 | 0.0100 | 133.3300 |
|
| NCI-H508 | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| NCI-H508 | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| NCI-H508 | triacsin C | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | trifluoperazine | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | triptolide | CTRP2,CTRP1 | 0.0000 | 0.2900 |
|
| NCI-H508 | TTK_3146 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | TTNBP | CTRP1 | 0.0260 | 3.3333 |
|
| NCI-H508 | Tubastatin A | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | TW 37 | GDSC1,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | tyrphostin AG-1478 | CTRP1 | 1.4787 | 189.2800 |
|
| NCI-H508 | ubistatin B | CTRP1 | 4.1667 | 533.3300 |
|
| NCI-H508 | UK 356618 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | Ulixertinib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | UNC0321 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | UNC0638 | GDSC1,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | UNC0642 | GDSC1 | 0.0020 | 0.5000 |
|
| NCI-H508 | UNC1215 | GDSC1 | 0.0039 | 1.0000 |
|
| NCI-H508 | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | ursolic acid | CTRP1 | 1.8247 | 233.5600 |
|
| NCI-H508 | VAF-347 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | valdecoxib | CTRP1 | 4.6250 | 592.0000 |
|
| NCI-H508 | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| NCI-H508 | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | Veliparib | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | Venetoclax | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| NCI-H508 | VER-155008 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| NCI-H508 | Vinblastine | GDSC1 | 0.0004 | 0.1000 |
|
| NCI-H508 | Vincristine | CTRP2 | 0.0041 | 130.0000 |
|
| NCI-H508 | Vinorelbine | GDSC2 | 0.0001 | 0.1000 |
|
| NCI-H508 | Vismodegib | GDSC1,GDSC2,CTRP1 | 0.0100 | 33.3330 |
|
| NCI-H508 | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Vorinostat | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| NCI-H508 | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | VX-11e | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | VX-702 | GDSC1 | 0.0078 | 2.0000 |
|
| NCI-H508 | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | Wee1 Inhibitor | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| NCI-H508 | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | Wnt-C59 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | WT-161 | CTRP1 | 0.2604 | 33.3330 |
|
| NCI-H508 | WZ4002 | CTRP2 | 0.0010 | 33.0000 |
|
| NCI-H508 | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | XAV939 | GDSC1,GDSC2,CTRP1 | 0.0050 | 37.0000 |
|
| NCI-H508 | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | XMD11-85h | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | XMD8-92 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | YK-4-279 | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| NCI-H508 | YL54 | CTRP2 | 0.0020 | 66.0000 |
|
| NCI-H508 | zebularine | CTRP2,CTRP1 | 0.0180 | 592.0000 |
|
| NCI-H508 | ZG-10 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | zileuton | CTRP1 | 4.1667 | 533.3300 |
|
| NCI-H508 | ZL049 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | ZL109 | GDSC1 | 0.0391 | 10.0000 |
|
| NCI-H508 | ZM336372 | CTRP1 | 2.6747 | 342.3700 |
|
| NCI-H508 | ZM447439 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| NCI-H508 | ZSTK474 | CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC